Influencing Factors of Intracranial Hypertension in Patients With

Status Completed

Clinical Trial Summary

Bilateral transverse sinus stenosis (BTSS) is associated with intracranial hypertension (IH). However, not every BTSS patients presented with IH. The risk factors of IH in BTSS patients remained obscure. Vertebral venous collaterals (VVC) were often found in patients with bilateral transverse sinus stenosis (BTSS). The purpose of this study was to investigate the physiological role of VVC in BTSS patients.

Clinical Trial Description

Bilateral transverse sinus stenosis (BTSS) is characterized by narrowing of bilateral transverse sinus which resulted in obstruction of venous reflux. The majority of BTSS patients exhibited with intracranial hypertension (IH) which manifested as a triad of headaches, tinnitus and papilledema. Stenting improved the symptoms in patients with transverse sinus stenosis (TSS) and reduced the elevated intracranial pressure (ICP). It is suggested that BTSS is one of the etiologies of IH. Since an alternative pattern of venous reflux was observed in patients with occluded superior sagittal sinus, it is postulated that altered pattern of venous reflux also exists in the presence of BTSS. The drainage of cerebral veins consists of two major pathways: transverse sinus-sigmoid sinus-internal jugular vein and vertebral venous plexus. Vertebral venous plexus is an extensive paravertebral system that provides direct venous communication between peritoneum and cranial cavity. The presence of vertebral venous collaterals (VVC) was reported in 108 consecutive patients. However, whether VVC is of physiological significance in BTSS patients remained unknown. This study was aimed to investigate the physiological role of VVC and whether it is involved in the regulation of IH and related clinical symptoms in BTSS patients.

Besides, it is presumed that serum uric acid (UA) may affect the formation of vertebral venous collaterals (VVC) and intracranial pressure (ICP). It is reported that UA inhibits the endothelial NO biological activity. High concentrations of uric acid (UA) suppresses circulating VEGF in Wistar rats and VEGF secretion in human endothelial cells. It is presumed that serum UA may affect the formation of VVC and ICP. The aim of this study is to investigate whether serum UA serves as an influencing factor of VVC and an indicator of IH in BTSS patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04492332
Study type	Interventional
Source	Capital Medical University
Contact
Status	Completed
Phase	N/A
Start date	January 2014
Completion date	December 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06367868` - Optic Nerve Sheath Diameter: A Non-Invasive Indicator of Intracranial Pressure in the Intensive Care Unit Monitoring	N/A
Completed	`NCT04488874` - Sodium Lactate and Brain Relaxation (LSD)	Phase 3
Not yet recruiting	`NCT04211064` - Comparison of the Effects of Deep and Moderate Neuromuscular Blockade on Optic Nerve Sheath Diameter	N/A
Completed	`NCT00571623` - Automated Chest Physiotherapy to Improve Outcomes in Neuro	N/A
Recruiting	`NCT00437814` - Effect of Ketamine (Ketalar) on Intracranial Pressure	N/A
Recruiting	`NCT03212976` - Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure	N/A
Withdrawn	`NCT02558309` - Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure	N/A
Terminated	`NCT00795587` - Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring	Phase 4
Completed	`NCT00447018` - Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial Pressure	Phase 4
Not yet recruiting	`NCT05593380` - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH	N/A
Completed	`NCT03364634` - Intracranial Pressure After Decompressive Craniectomy	N/A
Unknown status	`NCT02773901` - Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement	N/A
Terminated	`NCT01973764` - Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System	N/A
Terminated	`NCT00319345` - Sodium-Lactate and Traumatic Brain Injury	Phase 2/Phase 3
Recruiting	`NCT04459806` - Intracranial PrEssure Time dOse (ImPETO)
Completed	`NCT00239525` - 3-D Transcranial Ultrasound Analysis Study	N/A
Completed	`NCT05946200` - Optic Nerve Sheath Diameter in Low-flow and Normal-flow Rate Anesthesia	N/A
Completed	`NCT03957837` - Optical Nerve Sheath Changes During Head Down Laparoscopy
Not yet recruiting	`NCT05818371` - Non-invasive ONSD-based Neuromonitoring in a Neurointensive Care Setting	N/A
Completed	`NCT04429477` - Cerebral Compliance Impairment in COVID-19

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Influencing Factors of Intracranial Hypertension in Patients With Bilateral Transverse Sinus Stenosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms